Regeneron Pharmaceuticals (REGN) Earnings Date, Estimates & Call Transcripts $603.26 +14.92 (+2.54%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$599.88 -3.38 (-0.56%) As of 05/27/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Regeneron Pharmaceuticals Earnings Summary Regeneron Pharmaceuticals announced Q1 2025 earnings on April 29, 2025, reporting an EPS of $8.22, which missed analysts' consensus estimates of $8.83 by $0.61. Quarterly revenue fell 3.7% year-over-year to $3.03 billion, below analysts' expectations of $3.40 billion. With a trailing EPS of $39.28 and a P/E Ratio of 15.76, Regeneron Pharmaceuticals' earnings are expected to grow 5.85% next year, from $35.92 to $38.02 per share. Upcoming Q2 Earnings DateAug. 7Before Market OpensEstimatedConsensus EPS (Apr. 29) $8.83 Actual EPS (Apr. 29) $8.22 Missed By -$0.61 Actual Revenue (Apr. 29) $3.03BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckREGN Upcoming EarningsRegeneron Pharmaceuticals' next earnings date is estimated for Thursday, August 7, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Regeneron Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Regeneron Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataREGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.REGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Regeneron Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$7.07$7.07$7.07Q2 20251$8.22$8.22$8.22Q3 20251$9.62$9.62$9.62Q4 20251$9.56$9.56$9.56 Regeneron Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/7/2025(Estimated)--------4/29/2025Q1 2025$8.83$8.22 -$0.61$7.27$3.40B$3.03B2/4/2025Q4 2024$11.21$12.07+$0.86$8.06$3.76B$3.79B8/1/2024Q2 2024$8.93$11.56+$2.63$7.79$3.38B$3.55B5/2/2024Q1 2024$8.46$7.97 -$0.49$9.67$3.19B$3.15B2/2/2024Q4 2023$10.73$11.86+$1.13$10.17$3.29B$3.43B11/2/2023Q3 2023$9.39$10.17+$0.78$11.45$3.23B$3.36B8/3/2023Q2 2023$8.48$10.24+$1.76$9.08$3.02B$3.16B Regeneron Pharmaceuticals Earnings - Frequently Asked Questions When is Regeneron Pharmaceuticals's earnings date? Regeneron Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based off last year's report dates. Learn more on REGN's earnings history. Did Regeneron Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) missed the analysts' consensus estimate of $8.83 by $0.61 with a reported earnings per share (EPS) of $8.22. Learn more on analysts' earnings estimate vs. REGN's actual earnings. How can I listen to Regeneron Pharmaceuticals's earnings conference call? The conference call for Regeneron Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Regeneron Pharmaceuticals's conference call transcript? The conference call transcript for Regeneron Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Regeneron Pharmaceuticals generate each year? Regeneron Pharmaceuticals (NASDAQ:REGN) has a recorded annual revenue of $14.09 billion. How much profit does Regeneron Pharmaceuticals generate each year? Regeneron Pharmaceuticals (NASDAQ:REGN) has a recorded net income of $4.41 billion. REGN has generated $39.28 earnings per share over the last four quarters. What is Regeneron Pharmaceuticals's price-to-earnings ratio? Regeneron Pharmaceuticals (NASDAQ:REGN) has a trailing price-to-earnings ratio of 15.76 and a forward price-to-earnings ratio of 16.79. The price/earnings-to-growth ratio is 2.34. What is Regeneron Pharmaceuticals's EPS forecast for next year? Regeneron Pharmaceuticals's earnings are expected to grow from $35.92 per share to $38.02 per share in the next year, which is a 5.85% increase. More Earnings Resources from MarketBeat Related Companies AMGN Earnings GILD Earnings VRTX Earnings ALNY Earnings BIIB Earnings UTHR Earnings INCY Earnings NBIX Earnings EXEL Earnings BMRN Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBooz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong Earnings This page (NASDAQ:REGN) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
